One of the leading producers of rapid tests purged supplies and laid off workers as sales dwindled. Weeks later, the U.S. is facing a surge in infections with diminished capacity.
from NYT > Health https://ift.tt/3j4fsLb
August 20, 2021
Rose
Health - The New York Times, NYT > Health
No comments
Related Posts:
Nations weigh mandates and incentives to drive up vaccination rates.While some parts of the world have used lures such as free lottery tickets to lift inoculation rates, officials in a few places may go straight to requiring shots. from NYT > Health https://ift.tt/3vDe19E … Read More
CureVac’s Covid Vaccine Performed Badly in Trial, In Part Due to VariantsThe results were a blow to hopes that the vaccine could help meet the world’s urgent need. “This is pretty devastating” for the company, one expert said. from NYT > Health https://ift.tt/3iRcv0T … Read More
Weekly Health Quiz: Ticks, Exercise and a Vaccine MilestoneTest your knowledge of this week’s health news. from NYT > Health https://ift.tt/3iOruZm … Read More
Covid Proved the C.D.C. Is Broken. Can It Be Fixed?The pandemic revealed the glaring weaknesses of the world’s premier public health agency — and just how much work it would take to reform it. from NYT > Health https://ift.tt/2S6mfcO … Read More
Vaccine Maker Earned Record Profits but Delivered Disappointment in ReturnEmergent BioSolutions was awarded a $628 million federal contract with no competitive bidding. Top executives received big bonuses while factories mostly sat idle and tens of millions of Covid-19 doses were thrown away. from… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment